marketcaparena

ALMR

Alamar Biosciences, Inc.

Company overview

Market capitalization
$2.26B
Employees
222
Latest publication
2026-09-29
About Alamar Biosciences, Inc.

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USD
Total Revenue26,035,000USD13,091,000USD
Cost Of Revenue11,578,000USD6,702,000USD
Gross Profit14,457,000USD6,389,000USD
Research Development13,017,000USD8,302,000USD
Selling General Administrative13,787,000USD6,640,000USD
Total Operating Expenses26,804,000USD21,644,000USD
Operating Income-12,347,000USD-8,553,000USD
Interest Income539,000USD786,000USD
Interest Expense223,000USD46,000USD
Net Interest Income316,000USD740,000USD
Income Before Tax-20,861,000USD-7,659,000USD
Income Tax Expense464,000USD—
Tax Provision464,000USD0USD
Net Income-21,325,000USD-7,659,000USD
Net Income From Continuing Ops-21,325,000USD-7,659,000USD
Ebit-12,347,000USD—
Ebitda-11,180,000USD—
Depreciation And Amortization1,167,000USD—
Reconciled Depreciation1,167,000USD888,000USD
Total Other Income Expense Net-8,514,000USD154,000USD
Unclassified Operating Expenses—6,702,000USD
SourceLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
Total Revenue74,211,000USD25,142,000USD
Cost Of Revenue32,506,000USD16,535,000USD
Gross Profit41,705,000USD8,607,000USD
Research Development37,471,000USD39,234,000USD
Selling General Administrative35,568,000USD18,941,000USD
Total Operating Expenses73,039,000USD74,710,000USD
Operating Income-31,334,000USD-49,568,000USD
Interest Income2,160,000USD4,675,000USD
Interest Expense401,000USD2,078,000USD
Net Interest Income1,759,000USD2,597,000USD
Income Before Tax-29,154,000USD-47,060,000USD
Income Tax Expense665,000USD—
Tax Provision665,000USD13,000USD
Net Income-29,819,000USD-47,073,000USD
Net Income From Continuing Ops-29,819,000USD-47,073,000USD
Ebit-31,334,000USD—
Ebitda-27,470,000USD—
Depreciation And Amortization3,864,000USD—
Reconciled Depreciation3,864,000USD3,194,000USD
Total Other Income Expense Net2,180,000USD-89,000USD
Unclassified Operating Expenses—16,535,000USD
SourceLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USD
Total Assets186,451,000USD
Intangible Assets1,836,000USD
Other Current Assets12,532,000USD
Total Liab364,522,000USD
Total Stockholder Equity-178,071,000USD
Other Current Liab14,704,000USD
Common Stock1,000USD
Capital Stock1,000USD
Retained Earnings-190,100,000USD
Cash64,586,000USD
Cash And Short Term Investments64,586,000USD
Total Current Assets136,573,000USD
Total Current Liabilities24,048,000USD
Current Deferred Revenue2,110,000USD
Net Debt275,959,000USD
Short Term Debt1,599,000USD
Short Long Term Debt Total340,545,000USD
Long Term Debt74,971,000USD
Net Receivables19,524,000USD
Inventory39,931,000USD
Accounts Payable5,635,000USD
Property Plant Equipment Net36,143,000USD
Property Plant Equipment Gross36,143,000USD
Accumulated Other Comprehensive Income-80,000USD
Common Stock Shares Outstanding69,311,186shares
Non Current Assets Total49,877,999USD
Non Current Liabilities Total340,474,000USD
Non Current Liabilities Other1,197,000USD
Non Currrent Assets Other6,991,999USD
Net Working Capital117,425,000USD
Unclassified Non Current Assets4,907,000USD
Unclassified Non Current Liabilities264,306,000USD
Unclassified Equity12,107,000USD
SourceLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
Total Assets139,992,000USD149,511,000USD
Intangible Assets1,988,000USD2,044,000USD
Other Current Assets13,468,000USD5,609,000USD
Total Liab298,946,000USD282,922,000USD
Total Stockholder Equity-158,954,000USD-133,411,000USD
Other Current Liab15,289,000USD—
Common Stock1,000USD—
Capital Stock1,000USD1,000USD
Retained Earnings-168,775,000USD-138,956,000USD
Cash30,002,000USD26,770,000USD
Cash And Short Term Investments30,002,000USD—
Total Current Assets94,705,000USD106,697,000USD
Total Current Liabilities23,730,000USD16,591,000USD
Current Deferred Revenue470,000USD—
Net Debt11,471,000USD—
Short Term Debt2,099,000USD—
Short Long Term Debt Total41,473,000USD—
Long Term Debt9,810,000USD—
Short Term Investments0USD52,588,000USD
Net Receivables12,753,000USD6,648,000USD
Inventory38,482,000USD14,408,000USD
Accounts Payable5,872,000USD6,187,000USD
Property Plant Equipment Net36,628,000USD35,097,000USD
Property Plant Equipment Gross44,965,000USD40,654,000USD
Accumulated Other Comprehensive Income-72,000USD—
Common Stock Shares Outstanding66,521,424shares66,521,425shares
Non Current Assets Total45,287,000USD42,814,000USD
Non Current Liabilities Total275,216,000USD266,331,000USD
Non Current Liabilities Other599,000USD—
Non Currrent Assets Other6,671,000USD5,673,000USD
Net Working Capital70,975,000USD90,106,000USD
Unclassified Non Current Liabilities264,807,000USD266,331,000USD
Unclassified Equity9,891,000USD5,544,000USD
Unclassified Current Liabilities—10,404,000USD
SourceLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ1 20252025-03-31 · USD
Net Income-21,325,000USD-7,659,000USD
Depreciation1,167,000USD888,000USD
Stock Based Compensation1,467,000USD619,000USD
Other Non Cash Items11,199,000USD507,000USD
Change To Account Receivables-6,854,000USD-533,000USD
Change To Inventory-1,265,000USD-2,357,000USD
Change In Working Capital-11,388,000USD-7,062,000USD
Total Cash From Operating Activities-20,347,000USD-13,068,000USD
Capital Expenditures-600,000USD-982,000USD
Free Cash Flow-20,947,000USD-14,050,000USD
Investments0USD18,000,000USD
Total Cashflows From Investing Activities-778,000USD—
Net Borrowings56,500,000USD0USD
Total Cash From Financing Activities55,761,000USD243,000USD
Issuance Of Capital Stock1,803,000USD243,000USD
Change In Cash64,586,000USD4,326,000USD
Begin Period Cash Flow34,909,000USD31,677,000USD
End Period Cash Flow64,586,000USD36,003,000USD
Unclassified Operating Cash Flow-1,467,000USD—
Unclassified Financing Cash Flow-2,542,000USD—
SourceLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
Net Income-29,819,000USD-47,073,000USD
Depreciation3,864,000USD3,194,000USD
Stock Based Compensation2,870,000USD873,000USD
Other Non Cash Items2,047,000USD1,664,000USD
Change To Account Receivables-5,497,000USD-4,684,000USD
Change To Inventory-23,781,000USD-8,753,000USD
Change In Working Capital-32,570,000USD-11,989,000USD
Total Cash From Operating Activities-53,608,000USD-55,214,000USD
Capital Expenditures-6,384,000USD-3,388,000USD
Free Cash Flow-59,992,000USD-58,602,000USD
Investments52,560,000USD-50,545,000USD
Total Cashflows From Investing Activities46,176,000USD—
Net Borrowings10,000,000USD-15,000,000USD
Total Cash From Financing Activities10,836,000USD113,417,000USD
Issuance Of Capital Stock1,493,000USD128,417,000USD
Change In Cash3,232,000USD4,269,000USD
Begin Period Cash Flow31,677,000USD27,408,000USD
End Period Cash Flow34,909,000USD31,677,000USD
Other Cashflows From Investing Activities-1,011,000USD—
Other Cashflows From Financing Activities-657,000USD—
Unclassified Investing Cash Flow1,011,000USD—
Unclassified Operating Cash Flow—-1,883,000USD
SourceLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2026Quarterly · 2026-03-31GeographyAmericas1,287,000USD0001193125-26-213424
Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific2,409,000USD0001193125-26-213424
Q1 2026Quarterly · 2026-03-31GeographyEMEA3,972,000USD0001193125-26-213424
Q1 2026Quarterly · 2026-03-31GeographyUnited Kingdom3,462,000USD0001193125-26-213424
Q1 2026Quarterly · 2026-03-31GeographyUnited States14,905,000USD0001193125-26-213424
Q1 2026Quarterly · 2026-03-31ProductConsumables13,960,000USD0001193125-26-213424
Q1 2026Quarterly · 2026-03-31ProductInstruments7,381,000USD0001193125-26-213424
Q1 2026Quarterly · 2026-03-31ProductServices4,694,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31GeographyAmericas20,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific450,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31GeographyEMEA1,422,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31GeographyUnited Kingdom1,730,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31GeographyUnited States9,469,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31ProductConsumables5,023,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31ProductInstruments4,146,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31ProductProduct And Service Other250,000USD0001193125-26-213424
Q1 2025Quarterly · 2025-03-31ProductServices3,672,000USD0001193125-26-213424

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.